Background

Acute invasive fungal rhinosinusitis (AIFRS) is among the most severe illnesses that have reemerged in the COVID-19 era [1]. It is a rare and severe disease that primarily affects people who are immunocompromised. Neutropenia represents a significant risk factor specially in hematological malignancies [2].

The Acute invasive fungal rhinosinusitis is the worst type of fungal sinusitis, due to its high mortality [3]. Owing to significant morbidity and mortality with the development of vascular complications in patients with AIFRS, early identification, and rapid medical or surgical interventions are essential for improving patients’ outcomes [4].

Aspergillus and zygomycetes (rhizopus, mucor, and rhizomucor) are among the most often found fungi in AIFRS [5, 6]. Mucor has an angioinvasive characteristic, causing extensive tissue necrosis, severe mortality of about 50 to 80%, and high morbidity in patients who survive [7].

In computed tomography (CT), osseous erosions and extra-sinonasal extension which are suggestive of an invasive nature, are late features with restricted treatment window [8, 9].

In contrast, it has been shown that MRI is more sensitive in early detection of AIFRS [10]. Contrast enhanced T1WI with fat saturation are better for the evaluation of intracranial spread and development of vascular complications [11, 12]. The vascular manifestations include vascular mural thickening and enhancement, intraluminal arterial thrombosis, and dural venous sinus thrombosis [13].

Infection of ethmoid sinus entails a significant risk of extension of the inflammation into orbital apex, and cavernous sinus thrombosis. Another possibility is direct disease dissemination into the orbital apex with involvement of sphenoid sinus [14, 15].

Vascular complications in AIFRS are linked to significant morbidity and mortality. The sole means of reducing morbidity and improving patient outcomes are prompt diagnosis and urgent medical and surgical interventions. MRI is essential in the diagnosis and delineation of the disease extent [16].

This study purpose was to assess the MRI value in the early identification of vascular complications in patients with AIFRS and the effects of this early detection on patients’ outcomes.

Methods

This is an Institutional Review Board (IRB) approved retrospective study, with registration number 00412/2022, that was carried out on 32 patients, admitted to the radiology department from January 2021 to December 2021, their ages ranged between 40 and 65 years, eight patients have been excluded from the study as they underwent surgical debridement before doing MRI examination, the remaining 24 patients (12 males and 12 females) have been classified into 2 groups, based on the pathological findings, Group I that comprised 13 patients with mucormycosis, and Group II that comprised 11 patients with aspergillosis (Fig. 1). All the patients underwent paranasal sinus MRI. Follow up of the patients was done clinically for the next 4weeks.

Fig. 1
figure 1

Flow chart of the studied cases

Patients included in this study had immunocompromise states. The patients had clinical features suggestive of acute invasive fungal sinusitis, in addition to clinical features suspecting development of vascular complications such as neurological deficits, ophthalmoplegia, chemosis, vision loss, and involvement of the maxillary (V2) and mandibular (V3) divisions of trigeminal nerve, third or fourth cranial nerves.

All the patients were pathologically confirmed to have acute invasive fungal rhinosinusitis and underwent MRI evaluation.

Patients who performed surgical debridement before doing MRI evaluation, patients who are immunocompetent, who did not have clinical features suggesting vascular complications of invasive fungal sinusitis and patients who did not undergo MRI evaluation or the MRI studies were significantly degraded due to motion were excluded.

All included patients in our study were reviewed as regard to the following: patients’ demographics, clinical data, surgical type (endoscopic surgical debridement, or combined), pathology confirmation of the pathogen (mucormycosis, versus aspergillosis), presence of COVID-19, and patients’ survival.

The MRI was performed on 1.5T MRI Scanner (Optima 450 W GEM suite MRI; GE Healthcare, Seattle, Washington, USA) using an eight-channel head coil. Multiplanar, Multi Echo MRI of the paranasal sinuses’ sections were acquired.

For anatomical assessment and signal characterization, the sinus protocol included axial T1WI, axial and coronal T2WI fat-saturated sequences. Diffusion-weighted imaging (DWI) was obtained with b value of 0, and 1000 mm2/sec. To distinguish true diffusion from such pitfalls as T2 shine through, the apparent diffusion coefficient (ADC) maps were automatically generated. ADC value of all cases reported was determined in ADC map considering a 5 cm region of interest (ROI) as central as possible and in the most significant part of the vascular complication. ROI was manually positioned in full concordance with 3 observers with experience in sinonasal evaluation by MRI. Mean ADC values generated by the ROIs in each ADC map positioning was addressed to the respective case report. With the exception of four individuals with compromised renal function, postcontrast fat-saturated T1WIs were obtained 20–30 s after intravenous injection of 0.1 mmol/kg of gadopentetate dimeglumine (Magnevist; Schering, Berlin, Germany), injected manually at a rate of 2 mL/sec. The orbit cuts were covered in the field of view. To detect intracranial extension, axial T2WI, axial Fluid-attenuated inversion recovery (FLAIR), and postcontrast T1WI fat-saturated sequences of the whole brain were obtained. Imaging parameters are shown in (Table 1).

Table 1 Imaging parameters of standard MRI sequences

Experienced two neuroradiologists, with 10 and 5 years of experience, separately and blinded from the patients' clinical data and pathological findings assessed MR images on a workstation using Horos DICOM viewer. The sinuses were evaluated separately to determine the extent and site of disease i.e., maxillary, frontal, sphenoid, anterior and posterior ethmoid sinuses, and side of disease involvement i.e., right, left, or bilateral. Then each subsite has been evaluated for the presence of: mucosal thickening, and enhancement, signal of the sinus contents on T1 and T2WIs, and signal on diffusion weighted imaging. Special attention was paid for the involvement of the sinonasal walls, and periantral fat spaces. Pre- and post-septal cellulitis were observed as the spread into the orbit; post-septal cellulitis is often characterized by soft tissue stranding posterior to the orbital septum with varying degrees of proptosis. DWI sequence, which displays restricting wall and the endocavitary projections, sparing the lesion core, is high specific for fungal abscess. Vascular structures were assessed carefully to determine development of vascular complications. The ICA involvement has been determined according to the following findings: ICA attenuation which is noted as mural thickening, luminal narrowing and enhancement of the vessel wall on black blood postcontrast T1WIs fat-saturated images. Evaluation of the ICA also included determination of the presence of intraluminal thrombosis, seen as lack of signal void on T2 WI or filling defects on contrast enhanced sequence; and the development of ICA pseudoaneurysm. Cavernous sinus has been evaluated for the presence of thrombosis which manifests as changes in the size, contour, the signal intensity of cavernous sinus as well as the increased dural enhancement along the cavernous sinus lateral border. Other vascular issues such as ophthalmic vein thrombosis was evaluated, and it may manifest as a dilated intra-orbital cord-like structure above the optic nerve with loss of the normal flow void in the thrombosed vein.

Statistical Package for the Social Sciences (SPSS) (version 21) (SPSS Inc.- Chicago, IL) was used to compile and analyze our data. Age and other continuous variables are shown as means (± deviation [SD]), and percentages and relative frequency distributions are used to present categorical variables. To test for normality, the Shapiro–Wilk test was used. As a result, the Mann–Whitney (t) test or the Student's t-test were used to compare the continuous variables. The Chi-squared test (X2) was performed to determine the percentage of participants with opacification for categorical variables (e.g., sex, vascular complications, surgery type, COVID-19 status, and mortality). To determine whether there was a difference between any two groups that was statistically significant, the one-way ANOVA (F) test was utilized. The threshold for the statistical significance was set at p ≤ 0.05.

Results

The 32 patients with histopathological proven Acute invasive fungal rhinosinusitis (AIFRS) had different symptoms such as facial pain or loss sensation, visual loss, nasal congestion, epistaxis, cavernous sinus thrombosis and cranial nerve involvement, history of other comorbidities, like COVID-19 (was the risk factor in 54.17% of the cases) and other immunocompromise states like diabetes mellitus, complete clinical examination, laboratory and histopathological findings were collected and analyzed retrospectively. The mean age of the patients was 54.67 ± 5.26 years, and half of them were males (12 patients, 50%). There was no significant correlation between surgical types nor presence of COVID-19 with age and sex among the studied groups (P = 0.895) (Table 2).

Table 2 Socio demographic in relation to pathology findings

Involvement of the bilateral maxillary, sphenoid, ethmoid sinuses were most frequent among patients with mucormycosis by 23.08% of mucormycosis cases. While the right maxillary and sphenoid sinuses were the most frequently involved among patients with aspergillosis by 18.18% of aspergillosis cases, with a significant level of 0.023 (Fig. 2).

Fig. 2
figure 2

Location of sinusitis in relation to pathology findings

The degree of paranasal sinus mucosal disease ranged between subtle mucosal thickening (15%), sinus opacification (75%), sinus opacification and expansion (10%). The sinus contents showed T1WI intermediate to hypointense signal, T2WI variably hyperintense signal with fungal hyphae of hypointense signal, associated with fluid or hemorrhagic changes in 12% of cases. Fat suppressed post contrast enhanced T1WI showed loss of normal sinus mucosal enhancement “denoting necrosis” (55%), enhancing extra-sinus soft tissue (70%). Some cases showed peripheral mucosal enhancement. In most cases (90%) the sinus contents showed restricted diffusion on DWI. All cases showed variable degrees of extra-sinus extension to different anatomical zones, to the pterygopalatine fossa (64%), periantral fat (preantral and retromaxillary) (92%), to the orbit as postseptal cellulitis (44%), and to the brain as meningitis and cerebritis (35%).

Out of the mentioned 13 cases of mucormycosis; 4 (33.33%) cases had ICA attenuation, 8 (61.54%) cases had ICA thrombosis, only one (7.69%) case had ICA pseudoaneurysm, 7 (53.85%) cases had cavernous sinus thrombosis and 4 (33.33%) cases had ophthalmic vein thrombosis.

Out of the mentioned 11 cases of aspergillosis; no (0%) cases had ICA attenuation, 7(63.64%) cases had ICA thrombosis, only one (1.09%) case had ICA pseudoaneurysm, 9 (81.82%) cases had cavernous sinus thrombosis and 5 (45.45%) cases had ophthalmic vein thrombosis.

Regarding the vascular complications, involvement of the ICA was noticed in 21 out of 24 cases; 15 cases had ICA thrombosis (Fig. 3), 4 cases had ICA attenuation while only two cases had ICA pseudoaneurysm (Fig. 4), and the cavernous sinus thrombosis was reported in 16 out of 24 cases (Fig. 5), while the superior ophthalmic vein thrombosis was noticed in 9 out of 24 cases (Fig. 6). Combined involvement of both cavernous sinus and ICA thrombosis, cavernous sinus and superior ophthalmic vein thrombosis was noticed in 10 cases for each (Fig. 7). The ICA attenuation was found in patients with mucormycosis by (33.33%), with a significant difference (P = 0.044). While there was no significant correlation between pathology findings with ICA thrombosis, pseudo aneurysm, cavernous sinus thrombosis, ophthalmic vein thrombosis, surgery types,

Fig. 3
figure 3figure 3

A 46-year-old female patient presenting after 2 weeks of COVID-19 infection with AIFS, histopathological proven to be mucormycosis. A, B axial T2W MRIs revealed loss of the signal void in the cavernous segment of the left ICA denoting thrombosis. C coronal T2WI, D coronal contrast enhanced T1W MRI showed left superior ophthalmic vein thrombosis (orange arrow), enhancing left intra-orbital soft tissue infiltration (white arrow), mucosal thickening of left maxillary sinus and left inferior nasal turbinectomy. E, F axial non-contrast enhanced T1W MRIs with fat suppression showed thrombosis of the petrous and cavernous segments of the left ICA. G, H axial contrast enhanced T1W MRIs with fat suppression showed heterogenous enhancement of the left ICA thrombosis. I DW MRI, J ADC map revealed mild restricted diffusion at the left ICA thrombosis

Fig. 4
figure 4

A 41-year-old male patient presenting with AIFS, histopathological proven to be aspergillosis. A axial, B coronal T2W MRIs revealed pseudoaneurysmal dilatation in the cavernous segment of the right ICA, right spheno ethmoidal sinusitis. C axial non-contrast enhanced T1W MRI revealed hypointense signal within the pseudoaneyrysm. D axial contrast enhanced T1W MRI with fat suppression showed partial heterogenous enhancement of the ICA pseudoaeurysm denoting partial thrombosis. E DW MRI, F ADC map revealed free diffusion at the right ICA pseudoaneurysm

Fig. 5
figure 5

A 45-year-old male patient presenting with AIFS, histopathological proven to be aspergillosis. A, B axial T2W MRIs revealed left ICA and left cavernous sinus thrombosis (orange arrow), fungal sphenoid sinusitis (yellow arrow) and soft tissue infiltration of the left upper eyelid by extension along the left ophthalmic nerve (white arrow). C coronal T2W MRI showed left ophthalmic nerve involvement (arrow), left middle and inferior nasal turbinectomy. D axial non-contrast enhanced T1W MRI revealed loss of the signal void within the left ICA and left cavernous sinus denoting thrombosis. E DW MRI, F ADC map revealed restricted diffusion at the left cavernous sinus thrombosis

Fig. 6
figure 6

A 53-year-old female patient presenting after 3 weeks of COVID-19 infection with AIFS, histopathological proven to be mucormycosis. A axial T2WI, B coronal T2W MRI revealed thrombosis in the cavernous segment of the right ICA (orange arrow) and thrombosis in the right superior ophthalmic vein (yellow arrow), right posterior ethmoid sinusitis. C axial non-contrast enhanced T1W MRI revealed loss of the signal void within the right ICA cavernous segment denoting thrombosis. D DW MRI, E ADC map revealed restricted diffusion at the right ICA and right superior ophthalmic vein thrombosis

Fig. 7
figure 7

A 62-year-old female patient presenting with AIFS, histopathological proven to be mucormycosis. No history of COVID-19 infection. A axial T2WI, B, C coronal T2W MRIs revealed thrombosis in the cavernous segment of the left ICA, left cavernous sinus thrombosis and left superior ophthalmic vein thrombosis, left sphenoid sinusitis and bilateral middle and inferior nasal turbinectomy. D DW MRI, E ADC map revealed restricted diffusion at the left ICA thrombosis

COVID-19, and mortality (P = 0.774) (Table 3). Cavernous sinus thrombosis and ophthalmic vein thrombosis were significantly increased among non-survivor patients (90.00%, 70.00%), as compared to survivor patients (50.00%, 14.29%) respectively, with P = 0.04 and 0.005 respectively (Table 4). We did not find statistically significant correlation of the other involved vascular structures to the patient’s survival.

Table 3 Vascular complications, surgery, COVID 19 and mortality in relation to pathology findings
Table 4 Vascular complications in relation to mortality of studied groups (N = 24)

There was no significant correlation between surgical types with vascular complications, COVID-19, and mortality (P > 0.05). Likewise, there was no significant relation between COVID-19 with vascular complications (p > 0.05), and mortality (p = 0.188) among the studied patients (Table 5).

Table 5 Vascular complications and mortality in relation to COVID-19 (N = 24)

There was an almost perfect inter-observer agreement between the two expert neuroradiologists (Fleiss’ K with 95% confidence interval).

Discussion

The vascular complications in AIFRS are the most terrifying ones because they are associated with high morbidity and mortality rates, as vascular invasion by fungi can result in hemorrhagic or ischemic strokes with cerebral infarction calling for increased awareness. It is important to recognize these issues as joint surgical and medical emergencies [17].

This study purpose was to assess the MRI value in the early identification of vascular complications in patients with AIFRS and the effects of this early detection on patients’ outcomes.

In our study, regarding ICA complications, we found that ICA thrombosis was the most frequent ICA complication (71.4% of the cases), the cavernous sinus thrombosis and ophthalmic vein thrombosis were significantly increased among the non survivor patients, as compared to the survivor patients. Other vascular complications did not have significant correlation with mortality of studied groups. There is a significant propensity for the arterial invasion in mucorales' infection [18, 19]. Cavernous sinus thrombosis is a fatal condition that may call for a neurosurgeon's assistance. It frequently results from a hematogenous spread. It often becomes involved because of how close it is to the sphenoid sinus [20].

The least frequent ICA complication was found to be ICA pseudoaneurysm, representing only 9.5% of the cases. A small number of cases of the uncommon mycotic aneurysms have been documented thus far. They virtually always result in death, with high fatality rates ranging from 85 to 100%. The aspergillus fungus is mostly the cause. They have a propensity of invading blood vessels, resulting in aneurysmal dilatations, cerebral infarction, subarachnoid haemorrhage, and eventually death [21].

The present study showed that, mucormycosis pathology was more common among the studied patients (n = 13, 54.17%), than aspergillosis (n = 11, 45.83%) with a borderline significant difference (P = 0.050). Our study was close to the study of Shaban et al. [22] who found that the most isolated fungal pathogens were Mucor species (77.8%), followed by the aspergillus fumigatus (22.4%). Raab et al. [23] noted, Aspergillus spp. can also cause invasive fungal sinusitis, making Mucorales not the only fungal pathogens that can infect the paranasal sinuses.

In our study the mortality rate was 41.66% and the survival rate was 58.33% which are comparable with the findings of Shaban et al. [22] where the overall mortality was 40.7%, and also comparable with the findings of Turner et al. [5] who reported overall survival rate of 49.7%, and Allensworth et al. [24] who reported a survival rate of (68%) that was nearly identical to that reported in Malleshappa et al. [25] which stated an overall survival rate of 68.2%.

This study had some limitations, first, it was a single institutional study with a retrospective study design, second, lack of data in the literature discussing the entity of vascular complications in AIFRS, also the contraindication to contrast material injection in some patients, limits the optimal evaluation of vascular structures in those patients. Finally, there were only limited long-term clinical outcomes available.

Conclusions

Mortality of AIFRS is still high in spite of improvements in medical and surgical treatment. COVID-19 is a major risk factor of getting AIFRS. Contrast-enhanced MRI plays a crucial role in detecting and diagnosing AIFRS, assessing the extent of involvement, guiding treatment protocols, predicting and identifying the complications especially, the vascular complications that are common and devastating complications in AIFRS patients with higher risk morbidity and mortality.